(VIANEWS) – Omega Healthcare Investors (OHI), Oaktree Specialty Lending Corporation (OCSL), LeMaitre Vascular (LMAT) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Omega Healthcare Investors (OHI)
76.3% sales growth and 6.45% return on equity
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Earnings Per Share
As for profitability, Omega Healthcare Investors has a trailing twelve months EPS of $1.03.
PE Ratio
Omega Healthcare Investors has a trailing twelve months price to earnings ratio of 32.38. Meaning, the purchaser of the share is investing $32.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.45%.
Yearly Top and Bottom Value
Omega Healthcare Investors’s stock is valued at $33.35 at 01:22 EST, under its 52-week high of $34.14 and way above its 52-week low of $25.61.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 23.3% and positive 78.9% for the next.
2. Oaktree Specialty Lending Corporation (OCSL)
31% sales growth and 6.1% return on equity
Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.
Earnings Per Share
As for profitability, Oaktree Specialty Lending Corporation has a trailing twelve months EPS of $1.23.
PE Ratio
Oaktree Specialty Lending Corporation has a trailing twelve months price to earnings ratio of 16.39. Meaning, the purchaser of the share is investing $16.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.1%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Sep 13, 2023, the estimated forward annual dividend rate is 2.2 and the estimated forward annual dividend yield is 10.91%.
Yearly Top and Bottom Value
Oaktree Specialty Lending Corporation’s stock is valued at $20.16 at 01:22 EST, under its 52-week high of $21.69 and way higher than its 52-week low of $17.58.
Revenue Growth
Year-on-year quarterly revenue growth grew by 61.4%, now sitting on 347.52M for the twelve trailing months.
Moving Average
Oaktree Specialty Lending Corporation’s worth is higher than its 50-day moving average of $20.00 and higher than its 200-day moving average of $19.69.
3. LeMaitre Vascular (LMAT)
22.7% sales growth and 9.31% return on equity
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular patches, which are used for closure of vessels after surgical intervention; closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Earnings Per Share
As for profitability, LeMaitre Vascular has a trailing twelve months EPS of $1.13.
PE Ratio
LeMaitre Vascular has a trailing twelve months price to earnings ratio of 49.37. Meaning, the purchaser of the share is investing $49.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.31%.
Sales Growth
LeMaitre Vascular’s sales growth is 22% for the present quarter and 22.7% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
LeMaitre Vascular’s EBITDA is 6.6.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 20% and 36%, respectively.
4. Texas Capital Bancshares (TCBI)
9.6% sales growth and 12.02% return on equity
Texas Capital Bancshares, Inc. operates as the bank holding company for Texas Capital Bank, National Association that provides various banking products and services for commercial businesses, and professionals and entrepreneurs. It offers business deposit products and services, including commercial checking accounts, lockbox accounts, and cash concentration accounts, as well as other treasury management services, including information services, wire transfer initiation, ACH initiation, account transfer, and service integration; and consumer deposit products, such as checking accounts, savings accounts, money market accounts, and certificates of deposit. The company also provides commercial loans for general corporate purposes comprising financing for working capital, internal growth, and acquisitions, as well as financing for business insurance premiums; real estate term and construction loans; mortgage warehouse lending; mortgage correspondent aggregation; equipment finance and leasing; treasury management services, including online banking and debit and credit card services; escrow services; and letters of credit. In addition, it offers personal wealth management and trust services; secured and unsecured loans; and online and mobile banking services. Further, the company provides American Airlines AAdvantage, an all-digital branch offering depositors. It operates in Austin, Fort Worth, Dallas, Houston, and San Antonio metropolitan areas of Texas. Texas Capital Bancshares, Inc. was founded in 1996 and is headquartered in Dallas, Texas.
Earnings Per Share
As for profitability, Texas Capital Bancshares has a trailing twelve months EPS of $6.83.
PE Ratio
Texas Capital Bancshares has a trailing twelve months price to earnings ratio of 8.97. Meaning, the purchaser of the share is investing $8.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.02%.
5. Graham Holdings Company (GHC)
5.4% sales growth and 5.27% return on equity
Graham Holdings Company, through its subsidiaries, operates as a diversified education and media company in the United States and internationally. It provides test preparation services and materials; professional training and exam preparation for professional certifications and licensures; and non-academic operations support services to the Purdue University Global; operations support services for online courses and programs; training and test preparation services for accounting and financial services professionals; English-language training, academic preparation programs, and test preparation for English proficiency exams; and A-level examination preparation services, as well as operates colleges, business school, higher education institution, and an online learning institution. The company also owns and operates television stations, restaurants, and entertainment venues; engages in the financial training and automobile dealerships business; offers social media management tools to connect newsrooms with their users; produces Foreign Policy magazine and ForeignPolicy.com website; and publishes Slate, an online magazine, as well as French-language news magazine websites at slate.fr and slateafrique.com. In addition, it provides social media marketing solutions; home health, hospice, and palliative services; burners, igniters, dampers, and controls; screw jacks, linear actuators, and related linear motion products, and lifting systems; pressure impregnated kiln-dried lumber and plywood products; digital advertising services; power charging and data systems, industrial and commercial indoor lighting solutions, and electrical components and assemblies; dermatology and professional aesthetics, and skin care services; software and services; and operates pharmacy. The company was formerly known as The Washington Post Company and changed its name to Graham Holdings Company in November 2013. Graham Holdings Company was founded in 1877 and is based in Arlington, Virginia.
Earnings Per Share
As for profitability, Graham Holdings Company has a trailing twelve months EPS of $44.72.
PE Ratio
Graham Holdings Company has a trailing twelve months price to earnings ratio of 12.8. Meaning, the purchaser of the share is investing $12.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.27%.
Yearly Top and Bottom Value
Graham Holdings Company’s stock is valued at $572.47 at 01:22 EST, way below its 52-week high of $681.70 and above its 52-week low of $525.58.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.4%, now sitting on 4.21B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 49.5% and a negative 33.4%, respectively.
Volume
Today’s last reported volume for Graham Holdings Company is 4968 which is 71.3% below its average volume of 17315.
